This HTML5 document contains 131 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n10http://dx.doi.org/10.1128/

Statements

Subject Item
wd:Q33980321
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ article científic 2000年论文 2000年論文 научни чланак teaduslik artikkel naučni članak مقالة علمية 2000年论文 บทความทางวิทยาศาสตร์ artikulong pang-agham 2000年論文 2000年论文 vitenskapelig artikkel научная статья 2000 թվականի օգոստոսին հրատարակված գիտական հոդված bilimsel makale наукова стаття, опублікована в серпні 2000 tieteellinen artikkeli wetenschappelijk artikel سائنسی مضمون articol științific article scientifique (publié 2000) 2000年の論文 vedecký článok mokslinis straipsnis 2000년 논문 мақолаи илмӣ مقالهٔ علمی artykuł naukowy 2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած scienca artikolo ২০০০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак 2000年論文 vitskapeleg artikkel artikull shkencor 2000年論文 artigo científico (publicado na 2000) 2000年论文 научна статия artigo científico სამეცნიერო სტატია 2000 nî lūn-bûn bài báo khoa học 2000年论文 tudományos cikk videnskabelig artikel (udgivet 2000) scientific article vědecký článek article scientific מאמר מדעי wissenschaftlicher Artikel vetenskaplig artikel artículu científicu espublizáu en 2000 articolo scientifico artigo científico (publicado na 2000) 2000年論文 2000年论文 επιστημονικό άρθρο artículo científico publicado en 2000
p:P577
wds:Q33980321-74521E11-40D0-4A9F-855F-3E0209D75FC2
wdt:P577
2000-08-01T00:00:00Z
p:P407
wds:Q33980321-61750E1C-770A-4BAB-BC18-D377B4AF7EFA
wdt:P407
wd:Q1860
p:P2860
wds:Q33980321-F146BDD5-0746-4BAB-BEBA-1C5A2F0E8CED wds:Q33980321-63FE86B5-B3F5-4D27-A347-8475BAA0114D wds:Q33980321-64C0A5F7-8D45-415B-8477-FB3778B1634D wds:Q33980321-3A4C7376-3FE0-4562-8E65-2958C858D161 wds:Q33980321-43B56C9C-F1EF-483C-BE67-28FBEB151354 wds:Q33980321-C20BF914-846B-45FA-9894-81AEC07B80F5 wds:Q33980321-88240774-8E5A-4600-90CB-08CAD488585E wds:Q33980321-8C53FC63-75F9-4371-9EF7-89C64F0FB07D wds:Q33980321-9E40F97A-7C7B-494B-90A4-8C3B2CF47FD5 wds:Q33980321-048C27FF-07CD-4399-B0A2-C0FD0783F7BD wds:Q33980321-14B9B66E-A08D-4AD4-879A-8F7E6A75AF76 wds:Q33980321-2FC75083-D083-42A8-AFE5-DA2163092B4E
wdt:P2860
wd:Q74562312 wd:Q70738091 wd:Q50163746 wd:Q34729751 wd:Q34277330 wd:Q67929451 wd:Q34722938 wd:Q34722477 wd:Q34754721 wd:Q55033133 wd:Q54273580 wd:Q52044718
p:P2093
wds:Q33980321-DFCE7BE6-E49C-4A40-A93D-135697CD7C21 wds:Q33980321-EC8212E1-651B-4242-ACE4-EA47FEB06605 wds:Q33980321-E67DBB92-572B-4350-9D42-50D92F30E66D wds:Q33980321-095D9D0C-8AE3-477D-ACB0-3413D4BB1227 wds:Q33980321-A234C3E7-9D57-4604-A3E6-60C27BF4A813
wdt:P2093
L Riopel E Palazzini S Ke Z D Jiang H Dupont
rdfs:label
In vitro activity and fecal concentration of rifaximin after oral administration In vitro activity and fecal concentration of rifaximin after oral administration In vitro activity and fecal concentration of rifaximin after oral administration
skos:prefLabel
In vitro activity and fecal concentration of rifaximin after oral administration In vitro activity and fecal concentration of rifaximin after oral administration In vitro activity and fecal concentration of rifaximin after oral administration
schema:name
In vitro activity and fecal concentration of rifaximin after oral administration In vitro activity and fecal concentration of rifaximin after oral administration In vitro activity and fecal concentration of rifaximin after oral administration
p:P1476
wds:Q33980321-E3BF025C-4BF3-4486-8F9A-4DD405E8CF37
wdt:P1476
In vitro activity and fecal concentration of rifaximin after oral administration
p:P304
wds:Q33980321-F73CCF8F-5AB2-4B70-B719-085BA51AA214
wdt:P304
2205-2206
p:P31
wds:Q33980321-D9AF22FA-BB08-4D01-B88C-7814BCF3BDAB
wdt:P31
wd:Q13442814
p:P921
wds:Q33980321-8AFE9531-57EF-4FB6-9FCD-CB9D21B8A1B5
wdt:P921
wd:Q496
p:P698
wds:Q33980321-DC712D4D-50A8-41B6-B0F3-4D82753C495D
wdtn:P698
n12:10898704
wdt:P698
10898704
p:P1433
wds:Q33980321-63BE8629-86F7-4DB0-95CC-1218CA5B79C8
wdt:P1433
wd:Q578004
p:P433
wds:Q33980321-E84FF4C8-A700-48BB-8744-3D7A524473C8
p:P478
wds:Q33980321-D5FE6DBA-9311-4765-8BD0-1FAF1033B10D
wdt:P433
8
wdt:P478
44
p:P356
wds:Q33980321-C167EC1D-71BD-43AD-AAA7-2E51AD94DE66
wdtn:P356
n10:AAC.44.8.2205-2206.2000
wdt:P356
10.1128/AAC.44.8.2205-2206.2000
p:P932
wds:Q33980321-3F433816-7BDB-4DD2-A00F-CC692E5C953F
wdt:P932
90042